Search research articles
Contact Us
Filters
Showing results (91-100 of 500) with videos related to
Page
of 50
Sort By:
Cancer Chemotherapy and Biological Response Modifiers
|
August 23, 2005
T-cell genetic modification for re-directed tumor recognition
Laurence J N Cooper, Michael Kalos, David DiGiusto, et al.
Experimental Hematology
|
June 26, 2007
Antigen-independent and antigen-dependent methods to numerically expand CD19-specific CD8+ T cells
Tontanai Numbenjapon, Lisa M Serrano, Wen-Chung Chang, et al.
Leukemia & Lymphoma
|
March 20, 2020
The efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia with extramedullary involvement
Salman Otoukesh, Jianying Zhang, Ryotaro Nakamura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 23, 2010
Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans
Michael C Jensen, Leslie Popplewell, Laurence J Cooper, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 6, 2016
Cytogenetics Does Not Impact Outcomes in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
Ibrahim Aldoss, Ni-Chun Tsai, Marilyn L Slovak, et al.
Leukemia & Lymphoma
|
August 20, 2020
Retreatment with venetoclax and hypomethylating agents among AML patients who have relapsed after initial response and subsequent interruption of therapy
Tamer A Othman, Jianying Zhang, Matthew Mei, et al.
Cancer
|
March 29, 2002
Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy
Jun Wang, Lawrence M Weiss, Karen L Chang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 2, 2006
Target populations in allogeneic hematopoietic cell transplantation for autoimmune diseases--a workshop accompanying: cellular therapy for treatment of autoimmune diseases, basic science and clinical studies, including new developments in hematopoietic and mesenchymal stem cell therapy
Linda M Griffith, Steven Z Pavletic, Alan Tyndall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2005
Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides
Arturo Molina, Jasmine Zain, Daniel A Arber, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 2, 2007
Manufacturing of large numbers of patient-specific T cells for adoptive immunotherapy: an approach to improving product safety, composition, and production capacity
Chy-Anh Tran, Luciana Burton, Diana Russom, et al.
Page
of 50
Search research articles
Search
Showing results (91-100 of 500) with videos related to
Sort By:
Page
of 50
Cancer Chemotherapy and Biological Response Modifiers
|
August 23, 2005
T-cell genetic modification for re-directed tumor recognition
Laurence J N Cooper, Michael Kalos, David DiGiusto, et al.
Experimental Hematology
|
June 26, 2007
Antigen-independent and antigen-dependent methods to numerically expand CD19-specific CD8+ T cells
Tontanai Numbenjapon, Lisa M Serrano, Wen-Chung Chang, et al.
Leukemia & Lymphoma
|
March 20, 2020
The efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia with extramedullary involvement
Salman Otoukesh, Jianying Zhang, Ryotaro Nakamura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 23, 2010
Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans
Michael C Jensen, Leslie Popplewell, Laurence J Cooper, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 6, 2016
Cytogenetics Does Not Impact Outcomes in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
Ibrahim Aldoss, Ni-Chun Tsai, Marilyn L Slovak, et al.
Leukemia & Lymphoma
|
August 20, 2020
Retreatment with venetoclax and hypomethylating agents among AML patients who have relapsed after initial response and subsequent interruption of therapy
Tamer A Othman, Jianying Zhang, Matthew Mei, et al.
Cancer
|
March 29, 2002
Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy
Jun Wang, Lawrence M Weiss, Karen L Chang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 2, 2006
Target populations in allogeneic hematopoietic cell transplantation for autoimmune diseases--a workshop accompanying: cellular therapy for treatment of autoimmune diseases, basic science and clinical studies, including new developments in hematopoietic and mesenchymal stem cell therapy
Linda M Griffith, Steven Z Pavletic, Alan Tyndall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2005
Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides
Arturo Molina, Jasmine Zain, Daniel A Arber, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 2, 2007
Manufacturing of large numbers of patient-specific T cells for adoptive immunotherapy: an approach to improving product safety, composition, and production capacity
Chy-Anh Tran, Luciana Burton, Diana Russom, et al.
Page
of 50